- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有492家主力机构披露2025-06-30报告期持股数据，持仓量总计34.90亿股，占流通A股69.21%
- 波段诊断：
-
技术面诊股
诊断结果：5.9技术面打败了73%的股票
技术面评分前10的股票
近期的平均成本为5.10元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为5.10元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.10","date":1765788260,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2025.12.16","stock":"-1.17","trade":"-1.10","ind":"-1.11"},{"date":"2025.12.15","stock":"0.98","trade":"1.20","ind":"-0.55"},{"date":"2025.12.12","stock":"-1.17","trade":"-1.40","ind":"0.41"},{"date":"2025.12.11","stock":"-0.58","trade":"-2.88","ind":"-0.70"},{"date":"2025.12.10","stock":"1.77","trade":"0.86","ind":"-0.23"},{"date":"2025.12.09","stock":"-1.17","trade":"-2.48","ind":"-0.37"},{"date":"2025.12.08","stock":"0.59","trade":"0.41","ind":"0.54"},{"date":"2025.12.05","stock":"0.59","trade":"1.45","ind":"0.70"},{"date":"2025.12.04","stock":"0.40","trade":"-0.06","ind":"-0.06"},{"date":"2025.12.03","stock":"0.80","trade":"0.94","ind":"-0.51"},{"date":"2025.12.02","stock":"1.01","trade":"2.51","ind":"-0.42"},{"date":"2025.12.01","stock":"1.43","trade":"0.98","ind":"0.65"},{"date":"2025.11.28","stock":"-0.41","trade":"0.25","ind":"0.34"},{"date":"2025.11.27","stock":"-0.40","trade":"-0.96","ind":"0.29"},{"date":"2025.11.26","stock":"0.61","trade":"3.13","ind":"-0.15"},{"date":"2025.11.25","stock":"0.00","trade":"1.67","ind":"0.87"},{"date":"2025.11.24","stock":"0.82","trade":"0.50","ind":"0.05"},{"date":"2025.11.21","stock":"-2.60","trade":"-4.03","ind":"-2.45"},{"date":"2025.11.20","stock":"-0.40","trade":"-0.58","ind":"-0.40"},{"date":"2025.11.19","stock":"-0.59","trade":"-2.17","ind":"0.18"},{"date":"2025.11.18","stock":"-1.37","trade":"-1.50","ind":"-0.81"}]
九州通,上证指数,医药商业指数
压力支撑
该股压力位为5.09元，支撑位为5.03元。
[{"text":"\u538b\u529b\u4f4d","value":"5.09","date":1765814400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.03","date":1765814400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.9资金面打败了96%的股票
主力控盘前10的股票
行业资金
医药商业行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：12月16日 17:39
| 机构今日流向(万元) | -1687.45 | 机构5日流向(万元) | -9914.95 |
| 机构10日流向(万元) | -19792.87 | 机构20日流向(万元) | -28651.14 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加1794.22万股，其中基金净减仓14家，主力净增仓134家，请投资者中长期谨慎为宜。
截止2025-06-30，共492家主力机构（基金483家，一般法人9家），持仓量总计349001万股，占流通A股69.21%
其中，基金持仓与2024-12-31相比：
增仓：98家 ，增持 4731.88万股
减仓：112家 ，减持 2716.54万股
新出现在主力名单中：256家 ，持有15503.76万股
从主力名单中消失：122家 ，原持有13542.51万股
其中，基金持仓与2024-12-31相比：
增仓：98家 ，增持 4731.88万股
减仓：112家 ，减持 2716.54万股
新出现在主力名单中：256家 ，持有15503.76万股
从主力名单中消失：122家 ，原持有13542.51万股
消息面诊股
诊断结果：5.5消息面打败了65%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 九州通：12月15日获融资买入838.93万元
2025-12-16 - 九州通牵手海正CSO业务再添筹码 首年4亿布局零售
2025-12-16 - 4亿大单！九州通宣布重磅合作
2025-12-14 - 九州通：12月12日获融资买入996.53万元
2025-12-13 - 医药流通行业频现跨省并购，广药东进，江药北上
2025-12-12 - 海正药业与九州通达成战略合作 零售CSO项目同步启
2025-12-11 - 首版商保创新药目录发布：阿尔茨海默病新药纳入 肿瘤
2025-12-10 - 2025第十二届医药物流年会侧记：在九州通仓库，看
2025-12-10 - 2025年中国药品流通行业经营模式、行业政策、产业
2025-12-10 - 九州通，要开卖电子产品了！
2025-12-09
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-06 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-22 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-11-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-14 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-27 |
| 一般消息 | 募资投向 | 2025-08-05 | |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-07-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-07-05 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-29 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-04-29 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-03-13 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-03-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-12-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.0行业面打败了87%的股票
医药商业行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.12.16","price":"-1.11","value":"-1.10"},{"date":"2025.12.15","price":"-0.55","value":"1.20"},{"date":"2025.12.12","price":"0.41","value":"-1.40"},{"date":"2025.12.11","price":"-0.70","value":"-2.88"},{"date":"2025.12.10","price":"-0.23","value":"0.86"},{"date":"2025.12.09","price":"-0.37","value":"-2.48"},{"date":"2025.12.08","price":"0.54","value":"0.41"},{"date":"2025.12.05","price":"0.70","value":"1.45"},{"date":"2025.12.04","price":"-0.06","value":"-0.06"},{"date":"2025.12.03","price":"-0.51","value":"0.94"},{"date":"2025.12.02","price":"-0.42","value":"2.51"},{"date":"2025.12.01","price":"0.65","value":"0.98"},{"date":"2025.11.28","price":"0.34","value":"0.25"},{"date":"2025.11.27","price":"0.29","value":"-0.96"},{"date":"2025.11.26","price":"-0.15","value":"3.13"},{"date":"2025.11.25","price":"0.87","value":"1.67"},{"date":"2025.11.24","price":"0.05","value":"0.50"},{"date":"2025.11.21","price":"-2.45","value":"-4.03"},{"date":"2025.11.20","price":"-0.40","value":"-0.58"},{"date":"2025.11.19","price":"0.18","value":"-2.17"},{"date":"2025.11.18","price":"-0.81","value":"-1.50"}]
上证指数,医药商业行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 海王生物 | 59.77% | -8.21% | 5.6分 |
| 2 | 重药控股 | 20.73% | 23.45% | 5.4分 |
| 3 | 合富中国 | 18.55% | -3.61% | 4.7分 |
| 4 | 瑞康医药 | 12.58% | -19.43% | 5.4分 |
| 5 | 鹭燕医药 | 11.66% | 2.68% | 5.6分 |
| 6 | 华人健康 | 4.55% | 3.47% | 5.1分 |
| 8 | 英特集团 | -0.26% | -4.09% | 5.7分 |
| 10 | 上海医药 | -0.78% | 0.28% | 6.2分 |
| 12 | 开开实业 | -1.46% | -9.68% | 5.1分 |
| 14 | 国药股份 | -3.40% | -0.66% | 5.2分 |
| 16 | 大参林 | -3.88% | -0.46% | 5.9分 |
| 18 | 漱玉平民 | -5.22% | -5.41% | 4.6分 |
| 20 | 建发致新 | -5.71% | -6.75% | 4.4分 |
| 22 | 药易购 | -7.72% | -4.01% | 4.7分 |
| 24 | 润达医疗 | -8.45% | -6.82% | 3.7分 |
| 26 | 浙江震元 | -9.11% | -6.39% | 5.0分 |
| 28 | 第一医药 | -10.83% | -5.65% | 4.5分 |
| 30 | 塞力医疗 | -11.52% | -8.70% | 4.4分 |
| 32 | 人民同泰 | -36.12% | -11.35% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2012-09-12 | 增持 | 增持 |
| 国海证券 | 2012-09-11 | 中性 | - |
| 东兴证券 | 2012-09-11 | 增持 | 增持 |
| 平安证券 | 2012-09-10 | 增持 | 增持 |
| 华融证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13海岛建设股东股权质押
- 2012-09-13工大首创简式权益变动
- 2012-09-13华联综超选举公司第五届董事会董事长
- 2012-09-13积极追随政策把握市场热点方向
- 2012-09-13商贸零售行业：行业拐点仍需等待 选择确定性增长公司
- 2012-09-13卡奴迪路调研简报：渠道逆势持续扩张 明年增长新亮点
- 2012-09-13传言家乐福将退出中国市场 专家称可能性甚微
- 2012-09-13外资零售巨头在华遭遇困顿 专家分析八大原因
- 2012-09-13外资零售企业也须与时俱进
- 2012-09-13商务部谈电商价格战：正起草电子商务管理条例
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 9/72 ， 26/72。
[{"date":"2025-09-30","value":"7.12","vol":"4.89"},{"date":"2025-06-30","value":"5.26","vol":"3.26"},{"date":"2025-03-31","value":"3.50","vol":"1.75"},{"date":"2024-12-31","value":"9.79","vol":"4.53"},{"date":"2024-09-30","value":"6.73","vol":"5.67"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.12 | 5.26 | 3.50 | 9.79 | 6.73 |
| 行业(%) | 4.89 | 3.26 | 1.75 | 4.53 | 5.67 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"7.76","vol":"17.32"},{"date":"2025-06-30","value":"7.56","vol":"17.29"},{"date":"2025-03-31","value":"7.33","vol":"17.11"},{"date":"2024-12-31","value":"7.80","vol":"17.34"},{"date":"2024-09-30","value":"7.96","vol":"17.56"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
7.76 | 7.56 | 7.33 | 7.80 | 7.96 |
| 行业(%) | 17.32 | 17.29 | 17.11 | 17.34 | 17.56 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/72 ， 8/72。
[{"date":"2025-09-30","value":"5.20","vol":"-3.13"},{"date":"2025-06-30","value":"5.10","vol":"-3.59"},{"date":"2025-03-31","value":"3.81","vol":"-4.22"},{"date":"2024-12-31","value":"1.11","vol":"1.15"},{"date":"2024-09-30","value":"-0.82","vol":"2.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
5.20 | 5.10 | 3.81 | 1.11 | -0.82 |
| 行业(%) | -3.13 | -3.59 | -4.22 | 1.15 | 2.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"16.46","vol":"-5.36"},{"date":"2025-06-30","value":"19.70","vol":"-58.56"},{"date":"2025-03-31","value":"80.38","vol":"-44.86"},{"date":"2024-12-31","value":"15.33","vol":"-25.85"},{"date":"2024-09-30","value":"-6.99","vol":"-48.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
16.46 | 19.70 | 80.38 | 15.33 | -6.99 |
| 行业(%) | -5.36 | -58.56 | -44.86 | -25.85 | -48.83 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/72 ， 15/72。
[{"date":"2025-09-30","value":"1.11","vol":"0.85"},{"date":"2025-06-30","value":"0.77","vol":"0.57"},{"date":"2025-03-31","value":"0.40","vol":"0.29"},{"date":"2024-12-31","value":"1.56","vol":"1.20"},{"date":"2024-09-30","value":"1.17","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
1.11 | 0.77 | 0.40 | 1.56 | 1.17 |
| 行业(次) | 0.85 | 0.57 | 0.29 | 1.20 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.74","vol":"4.30"},{"date":"2025-06-30","value":"3.29","vol":"2.88"},{"date":"2025-03-31","value":"1.71","vol":"1.42"},{"date":"2024-12-31","value":"6.52","vol":"6.07"},{"date":"2024-09-30","value":"5.36","vol":"4.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
4.74 | 3.29 | 1.71 | 6.52 | 5.36 |
| 行业(次) | 4.30 | 2.88 | 1.42 | 6.07 | 4.38 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"1.32","vol":"4.37"},{"date":"2025-06-30","value":"1.30","vol":"6.90"},{"date":"2025-03-31","value":"-7.92","vol":"0.70"},{"date":"2024-12-31","value":"14.96","vol":"13.65"},{"date":"2024-09-30","value":"1.50","vol":"3.42"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 1.32 | 1.30 | -7.92 | 14.96 | 1.50 |
| 行业 | 4.37 | 6.90 | 0.70 | 13.65 | 3.42 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.64","vol":"0.54"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.08","vol":"0.86"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.64 | - | 1.08 | - |
| 行业 | 0.00 | 0.54 | 0.00 | 0.86 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 19/72 ， 12/72。
[{"date":"2025-09-30","value":"1.24","vol":"1.42"},{"date":"2025-06-30","value":"1.25","vol":"1.41"},{"date":"2025-03-31","value":"1.26","vol":"1.44"},{"date":"2024-12-31","value":"1.27","vol":"1.44"},{"date":"2024-09-30","value":"1.27","vol":"1.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.24 | 1.25 | 1.26 | 1.27 | 1.27 |
| 行业 | 1.42 | 1.41 | 1.44 | 1.44 | 1.43 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.85","vol":"0.99"},{"date":"2025-06-30","value":"0.86","vol":"0.99"},{"date":"2025-03-31","value":"0.87","vol":"1.01"},{"date":"2024-12-31","value":"0.84","vol":"1.02"},{"date":"2024-09-30","value":"0.90","vol":"1.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.85 | 0.86 | 0.87 | 0.84 | 0.90 |
| 行业 | 0.99 | 0.99 | 1.01 | 1.02 | 1.01 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 22/72 ， 8/72。
[{"date":"2025-09-30","value":"68.77","vol":"61.47"},{"date":"2025-06-30","value":"67.97","vol":"62.27"},{"date":"2025-03-31","value":"68.06","vol":"61.71"},{"date":"2024-12-31","value":"67.19","vol":"62.27"},{"date":"2024-09-30","value":"67.52","vol":"59.71"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
68.77 | 67.97 | 68.06 | 67.19 | 67.52 |
| 行业(%) | 61.47 | 62.27 | 61.71 | 62.27 | 59.71 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.73","vol":"2.39"},{"date":"2025-06-30","value":"2.64","vol":"2.48"},{"date":"2025-03-31","value":"2.62","vol":"2.47"},{"date":"2024-12-31","value":"2.53","vol":"2.50"},{"date":"2024-09-30","value":"2.58","vol":"2.12"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.73 | 2.64 | 2.62 | 2.53 | 2.58 |
| 行业(%) | 2.39 | 2.48 | 2.47 | 2.50 | 2.12 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2025-11-19 | 增持 | |
| 中信建投证券 | 2025-11-10 | 买入 | |
| 东方证券 | 2025-11-03 | 买入 | 买入 |
| 东吴证券 | 2025-11-02 | 买入 | |
| 中邮证券 | 2025-10-29 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"24.48","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"20.85","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"21.74","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"25.07","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"24.97","blueLineValue":"0.50","type":"YC"}]